SCHEMBL7533839

SCHEMBL7533839

Cc1cc(CSCC(C(=O)NO)N(C)S(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)no1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 3/20 0.49
MMP9 P14780 8/20 0.49
MMP13 P45452 8/20 0.49
MMP1 P03956 7/20 0.49
ADAM17 P78536 4/20 0.49
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
DUT P33316 1/20 0.41
HPGD P15428 1/20 0.40
MMP2 P08253 5/20 0.40
MMP3 P08254 3/20 0.40
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.38
CNR2 P34972 1/20 0.38
MMP7 P09237 2/20 0.37
MMP8 P22894 2/20 0.37
MMP14 P50281 2/20 0.37
ABCB11 O95342 1/20 0.37
MMP10 P09238 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533835 1.00 BMP1 (0.49) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7538438 0.92 BMP1 (0.49) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7538443 0.92 BMP1 (0.49) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7536288 0.84 BMP1 (0.51) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7536291 0.84 BMP1 (0.51) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7536984 0.83 MMP13 (0.51) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7536979 0.83 MMP13 (0.51) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7534007 0.83 MMP13 (0.54) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7534005 0.83 MMP13 (0.54) BMP1MMP9MMP13MMP1ADAM17
SCHEMBL7532363 0.80 MMP13 (0.51) MMP9MMP13MMP1ADAM17DUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US claimed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO claimed
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US disclosed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO disclosed